She receives salary support from the CPC, a non-profit academic research organization affiliated with the University of Colorado, that currently receives or has recently received grants or funding from the following organizations or their affiliates: 35Pharma, Abbott Laboratories, Agios Pharmaceuticals, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Amgen, Arrowhead Pharmaceuticals, AstraZeneca Pharmaceuticals, Autonomy Bio, Bayer Pharmaceuticals, Bristol Myers Squibb, Cleerly, CSL Behring, Eidos Therapeutics, EluraBio, Esperion Therapeutics, Faraday Pharmaceuticals, Gasherbrum Bio, Insmed, IsomAb, Johnson & Johnson, Lexicon Pharmaceuticals, Lilly USA, Medison Pharma, Merck Sharp & Dohme, Meridian Bioscience, Nectero Medical, NewAmsterdam Pharma, Novartis Pharmaceuticals, Novo Nordisk, Pfizer, Prothena Biosciences, Regeneron, Roche Holdings AG, Sanofi, Silence Therapeutics, Stealth BioTherapeutics, Tourmaline Bio, VarmX, Verve Therapeutics and Viz.ai
Intranasal administration through the olfactory pathway could enable researchers to investigate retatrutide effects on brain GLP-1, GIP, and glucagon receptors without the confounding variable of high peripheral peptide levels
3 Neuromodulatory effects of cannabinoids 3.1 Endocannabinoid signaling in the aging brain The molecular architecture of the ECS is defined by the presence of the CB1R and CB2R, together with their endogenous ligands, most notably AEA and 2-AG (Haspula and Clark, 2020)
Customizable & Expert Care: Tailored treatment plans that adapt to your unique needs and progress
